s
New Challenger Onboard? Syai Health Brings the New Fashion to CGM Experience & Chronic Disease Management
20-02-2024, 12:05
Syai Health secured significant funding from AstraZeneca plc & Xiaomi Corporation. SINGAPORE, Feb. 20, 2024 /PRNewswire/ — Singapore-based biotech company, Syai Health, abbreviated for “Sychronise + AI”, secured significant funding from leading investors like AstraZeneca plc and Xiaomi Corporation for its in-house developed AI-empowered medical devices. Originally an Oxford-Cambridge spinoff, alongside an R&D crew from […] L'articolo New Challenger Onboard? Syai Health Brings the New Fashion to CGM Experience & Chronic Disease Management proviene da La Ragione.
CONTINUA A LEGGERE
21
0
0
Guarda anche
La Ragione
Ieri, 21:43
Gakpo e Malen trascinano l’Olanda ai quarti, Romania ko 3-0
La Ragione
Ieri, 20:57
Calcio: Brasile, legge stabilisce 19 novembre il giorno di O’Rei Pelé
La Ragione
Ieri, 20:43
Pogacar vince sul Galibier in solitaria e torna in maglia gialla
La Ragione
Ieri, 19:43